Internal Medicine, Hematology & Oncology · Port Jefferson Station, NY
NPI
1649531815
Since 2012
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
4
Medicare group memberships
Hospitals
5
Hospital affiliations
49 Nesconset Hwy
Port Jefferson Station, NY, 11776
Phone (631) 751-0000
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.5M
179,784 services
Medicare patients, 2024
1,455
Average age 76
Drug cost, 2024
$7.9M
1,730 prescriptions
Company payments, 2025
$2,232
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Joshua Harris was code J1439 (injection, ferric carboxymaltose, 1 mg), 63,000 times for 69 patients. In total Joshua Harris billed 179,784 services in 197 codes, and Medicare paid $2.5M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-07-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 63,000 | 69 | $0.88 | $55K |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 13,920 | 21 | $2.32 | $32K |
| J1756 Injection, iron sucrose, 1 mg | Office | 11,000 | 29 | $0.17 | $1,899 |
| J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj | Office | 10,440 | 14 | $39.16 | $409K |
| J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 3,250 | 11 | $36.94 | $120K |
| 85025 Blood Count | Office | 2,799 | 1,030 | $7.60 | $21K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,665 | 86 | $0.09 | $232 |
| J0897 Injection, denosumab, 1 mg | Office | 2,580 | 23 | $20.63 | $53K |
| 36415 Venipuncture Blood Collection | Office | 2,248 | 902 | $8.65 | $19K |
| 99214 Office E&M - Established | Office | 1,711 | 803 | $109.87 | $188K |
| 80053 Clinical Chemistry | Office | 1,641 | 775 | $10.33 | $17K |
| 88185 Surgical Pathology Examination | Office | 1,334 | 57 | $21.84 | $29K |
| 84100 Clinical Chemistry | Office | 1,005 | 551 | $4.65 | $4,669 |
| 83615 Clinical Chemistry | Office | 966 | 526 | $5.91 | $5,713 |
| 84550 Clinical Chemistry | Office | 957 | 519 | $4.42 | $4,231 |
By year: 2022 $3.4M for 221,269 services; 2023 $2.5M for 164,605 services; 2024 $2.5M for 179,784 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 2,799 | 1,030 | $7.60 | $21K |
| 36415 Venipuncture Blood Collection | 2,248 | 902 | $8.65 | $19K |
| 80053 Clinical Chemistry | 1,641 | 775 | $10.33 | $17K |
| 88185 Surgical Pathology Examination | 1,334 | 57 | $21.84 | $29K |
| 84100 Clinical Chemistry | 1,005 | 551 | $4.65 | $4,669 |
| 83615 Clinical Chemistry | 966 | 526 | $5.91 | $5,713 |
| 84550 Clinical Chemistry | 957 | 519 | $4.42 | $4,231 |
| 83735 Clinical Chemistry | 250 | 142 | $6.57 | $1,643 |
| 82784 Immunoassay | 156 | 41 | $9.11 | $1,422 |
| 83550 Clinical Chemistry | 132 | 93 | $8.57 | $1,131 |
Medicare prescription drug claims, 2024
In 2024, the drug Joshua Harris prescribed most often to Medicare patients was Letrozole, with 100 prescriptions and refills. In total Joshua Harris wrote 1,730 Medicare prescriptions that cost $7.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 100 | 221 | 33 | $1,736 |
| Eliquis Apixaban | 91 | 129 | 33 | $71K |
| Revlimid Lenalidomide | 80 | 80 | 13 | $1.3M |
| Acyclovir Generic | 73 | 112 | 15 | $673 |
| Xarelto Rivaroxaban | 71 | 109 | 20 | $59K |
| Hydroxyurea Generic | 57 | 125 | 20 | $1,061 |
| Brukinsa Zanubrutinib | 56 | 56 | Under 11 | $831K |
| Prednisone Generic | 49 | 59 | 14 | $160 |
| Erleada Apalutamide | 49 | 49 | Under 11 | $728K |
| Dexamethasone Generic | 45 | 46 | 18 | $462 |
| Cefuroxime Cefuroxime Axetil | 38 | 40 | 18 | $1,109 |
| Pantoprazole Sodium Generic | 36 | 52 | 12 | $159 |
| Anastrozole Generic | 35 | 77 | Under 11 | $413 |
| Akynzeo Fosnetupitant/Palonosetron | 33 | 33 | Under 11 | $38K |
| Aranesp Darbepoetin Alfa In Polysorbat | 31 | 31 | Under 11 | $54K |
Brand drugs: - claims; generic drugs: 953 claims; opioid claims: 28.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Joshua Harris $2,232 ($2,232 in general payments such as food, travel and fees) from 7 companies. The largest payer was Janssen Biotech, Inc. with $1,010.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.